✦ LIBER ✦

The characteristics of malignant breast tumors in hormone replacement therapy users versus nonusers

✍ Scribed by Itzhak Pappo; Ioana Meirshon; Tamar Karni; Nava Siegelmann-Danielli; Varda Stahl-Kent; Judith Sandbank; Ilan Wasserman; Ariel Halevy

Book ID: 110547908
Publisher: Springer
Year: 2004
Tongue: English
Weight: 623 KB
Volume: 11
Category: Article
ISSN: 1068-9265
DOI: 10.1007/bf02524346

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast Tumor Characteristics in Hormone

Breast Tumor Characteristics in Hormone Replacement Therapy Users

✍ Jasmina-Ziva Cerne; Snjezana Frkovic-Grazio; Ksenija Gersak 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 116 KB

PCN6 RISK OF BREAST CANCER AMONG USERS O

PCN6 RISK OF BREAST CANCER AMONG USERS OF POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY IN TAIWAN

✍ Shen, WC; Lin, MS; Bai, CH; Chen, WC; Tang, CH 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Risk of venous thromboembolism in users

Risk of venous thromboembolism in users of hormone replacement therapy

✍ Edel Daly; Martin P Vessey; Michael M Hawkins; Jeffrey L Carson; Parimala Gough; 📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 40 KB

Prevalence of hormone replacement therap

Prevalence of hormone replacement therapy and user's characteristics: a community survey in Japan

✍ Chisato Nagata; Yoko Matsushita; Hiroyuki Shimizu 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 526 KB

The other side of estrogen replacement t

The other side of estrogen replacement therapy: Outcome study results of mood improvement in estrogen users and nonusers

✍ Karen J. Miller 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 339 KB

Hormone replacement therapy and breast c

Hormone replacement therapy and breast cancer in former users of oral contraceptives—The Norwegian Women and Cancer study

✍ Eiliv Lund; Kjersti Bakken; Vanessa Dumeaux; Vegard Andersen; Merethe Kumle 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB 👁 2 views

## Abstract Combined estrogen–progestin menopausal therapy (HRT) and combined estrogen–progestin contraceptives (OC) both increase breast cancer risk during current use and a few years after. We investigated risk of breast cancer in women who were users of HRT dependant on former history of OC use